Canadian biotech set to grow 9.4% year to 2030

December 21, 2011 at 9:58 am Leave a comment

The value of Canada’s biotechnology sector will grow by an annual average of 9.4% over the next 18 years and will reach C$144 billion by 2030, equal 4% of Canadian Gross Domestic Product (GDP).

Over the next two decades, Canada will enjoy a maturing biotechnology industry, and the significance of the sector will extend beyond the value of economic goods and serves to cover job creation, enhanced human health, reduced environmental damage and greater production capacity, says the study, which was carried out for the nonprofit corporation Genomics Canada by the Centre for the Study of Living Standards (CSLS).

CLINK: http://www.pharmatimes.com/Article/11-12-13/Canadian_biotech_set_to_grow_9_4_year_to_2030.aspx

Entry filed under: Of Interest. Tags: , , , .

Canadian researchers to start clinical trials of HIV vaccine Hockey and cognitive neurophysiology

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: